Yüklüyor......

p53 Expression by Immunohistochemistry is an Independent Determinant of Survival in Chronic Lymphocytic Leukemia Patients Receiving Frontline Chemo-Immunotherapy

Although chromosome 17p abnormalities and TP53 mutations are purported to be poor prognostic indicators in chronic lymphocytic leukemia (CLL), the significance of p53 expression in CLL has not been defined in patients uniformly treated with chemoimmunotherapy, nor has its utility in combination with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Leuk Lymphoma
Asıl Yazarlar: Schlette, Ellen J, Admirand, Joan, Wierda, William, Abruzzo, Lynne, O'Brien, Susan, Lerner, Susan, Keating, Michael J, Tam, Constantine
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4428664/
https://ncbi.nlm.nih.gov/pubmed/19863337
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!